---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-006580"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2025-08-29T23:59:59+00:00"
generated_at: "2026-05-17T09:10:24.473701+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals shareholders elect director, approve executive compensation and auditor

## Summary
- Dr. Jay Birnbaum elected Class II director with 123,034 votes for, 19,478 withheld.
- Non-binding advisory vote to approve named executive officer compensation passed 112,548 for, 26,360 against, 3,604 abstain.
- Ratification of Frazier & Deeter as auditor for FY ending March 31, 2026 passed with 702,484 for, 13,569 against, 2,416 abstain.
- Adjournment proposal passed with 576,908 for, 140,513 against, 1,048 abstain.

## SEC filing metadata
- accession: 0001683168-25-006580
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2025-08-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316825006580/0001683168-25-006580-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316825006580/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-006580
- JSON: https://secwatch.observer/filing/0001683168-25-006580.json
- Plain text: https://secwatch.observer/filing/0001683168-25-006580.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.